NEW YORK, June 21 (GenomeWeb News) - The Foundation for Innovative New Diagnostics, which is funded by the Bill & Melinda Gates Foundation, said that it has signed a letter of intent with Australian biotech Proteome Systems to "fast track" the development of a rapid antigen-based diagnostic test for active tuberculosis.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.